Study Information

Title: A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies External
Status: Recruiting participants
Conditions: Metastatic Castration-resistant Prostrate Cancer (mCRPC); Renal Cell Carcinoma (RCC); Metastatic Melanoma (MEL); Non-small Cell Lung Cancer (NSCLC)
Interventions: Biological: BMS-936558 (MDX-1106); Biological: BMS-936558 (MDX-1106); Biological: BMS-936558 (MDX-1106); Biological: BMS-936558 (MDX-1106); Biological: BMS-936558 (MDX-1106)
Institutions: Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Massachusetts General Hospital
Health Topics: Adenocarcinoma of the Lung, Kidney Cancer, Lung Cancer Overview, Melanoma, Squamous cell carcinoma of the lung

Contact Information


Beth Israel Deaconess Medical Center
Boston, MA 02215
Study Coordinator
617-632-9293
Dana-Farber Cancer Institute
Boston, MA 02115
Study Coordinator
617-582-7116
Massachusetts General Hospital
Boston, MA 02114
Study Coordinator
617-726-0605